US 9,492,559 B2
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofGeneral
US 9,492,559 B2
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Albert Navarro
Art Unit:
1645 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
Agent:
Inventors:
Wendy Jo Watson; Mingming Han; Jianxin Gu; Rajesh Kumar Kainthan; Emilio Anthony Emini; Avvari Krishna Prasad; Jin-Hwan Kim; Yu-ying Yang; David Cooper; Kathrin Ute Jansen; Michael William Pride
Assignee:
Priority:
01/21/14
Filed:
01/15/15
Granted:
11/15/16
Expiration:
01/21/34
Abstract
The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said novel immunogenic compositions.
Cooperative Patent Classification (CPC)
A61A61K2039/6037A61P31/04A61KY02A50/30Y02A